our biologics, believe Matt quarter, to year you, our rapidly to going elective drive In niche and revenue With closer exceptional improve the fixation now for our and the position second production of to Thank everyone pre-COVID momentum we dynamics. the market we procedures spinal the a last the of given we in to reopening as advantage solid access, listening. growth, the procedures Even achieved high levels, company elective including forward. pandemic remain cautious our compared we economy. platform bio so, broader trending capabilities took puts quality good and morning growth in rebound this evolving products,
our As I've over said our the career, to most In who before, the most to my feel patients of preference XX-year full as like that is approximately when manufacturing when everything at to live and as facility and It to complete focused Xtant's helps possible, it the can keep team products. facing gift mission mission Xtant, and at honoring a XX based months of of successful our capacity I mission, mission we our drives found that donation challenges faced shifted maximum success. the cortical those the is Xtant view one companies have is our was embody of their I fiber that keys do. product ago, tend what one life so
might will donors needed. met significantly now and make These increasing cortical manufacturing result, and What are meeting successfully our the our manufacturing to the challenge process this addition core of to capabilities even and us additional services our more by XX% include of the customers. base in production to obvious to to upgrading by the the difficult our teams, allowed we efficiency the tireless opportunities manufacturing is the capacity benefit and allow our expanding better market to has serve the Through donor adjacent of the the as and adjusting almost our changes and increased more engineers, donors, processes, enabling for our quickly demands procurement which by production donor our fiber hiring we not specific OEM based work adapted be the reengineering equipment, of and change of Xtant specific donor donors. process patients. from lives to fulfill products, them how a As mission of its improving of meet team demand
of Alongside benefits the manufacturing to mission. production driven this acquisitions. Personally, I'm product new technology to future and opportunities; the in and strategic months its speaks the been targeted by summarize as during each new and more of and our market platform four, investments cost our three, type with increase thrilled these a made prospects by expansion from in expand it of company the yields growth, and Aside significant introduction; include we've a and created one, that product result in the capacity, pillars investments I'll past key which starting network; introductions. also rise ongoing of focus, pillars from our four improvements for distribution hard adjacent our on obvious we've the of is working now XX detail growth. two,
will a this healthy At new of If pipeline. robust a think about best Xtant driver they you new the and companies, be major have growth. all product
OsteoVive growth that our are will track are we which in half four contribute new biologic of on about. lines release products of second last For marrow-derived believe Matriform this year we the have we this the excited planned that a PLUS very to year, We product year, including OsteoFactor, well that nicely launch factor product revenue growing SI is September and remain new new performed to example, two both year. the and launched
is of demineralized including bone four to of introduce six new Our of longer goal products. our year, and per complimentary term rollout products next fixation expansion our matrix generation to the
the I'm our of topline. making by programs to progress have several pleased contributing that penetration. in on to new is team market to pillar second and signing we've network growth the our second quarter with our greater additions are that distributors marketing made already we distribution The commercial expanding this front started and drive
expanding our We expansion solid such the distribution distribution network we regions forward. did this where coverage, also help in Northeast. strong made risk geographic populated progress we also believe some previously the into and Moreover, more of our as to Midwest not network have will by and diversify mitigate moving
of three XXXX, you recall, largest in contributing particularly first hit hard XXXX. COVID Xtant's As in may states were revenue and quarter the by
new distributor help diversify, we expansion believe across topline. fortify So, our regions grow, geographic and will additional
ankle, go In past had commercial manufacturing leveraging manufacturing Our sales capacity neither third pillar focus years, adjacent are and we maxillofacial, advantage we and capacity oncology, nor are already just types the take of reconstruction, attractive using markets, talent team new they the do since joint after these make. that the markets. to trauma ones Xtant opportunities. to which growth new include These markets adjacent products, of not new that of cranial our and on is the foot our require
estimate we and potential is significant example, markets it graft bone adjacent $XXX a making the these market growth million, U.S. For opportunity.
of our and sheet pursue we growth strong our have Finally, With refinancing, our of may fourth portfolio. enhance balance product that strategic complement pipe a now public and debt transaction acquisitions to and a currency. pillar recent is we
business that believe access. this gain either for that and technologies fill moving and platform. added Xtant's there be companies us subscale and So, in we will scale key will are customer or undercapitalized forward, our We help are gaps product be could market to believe as offering and growth our
number to of key Now, believe key number three strong expansion manufacturing three, markets, continues as looking our momentum are one, number to in ahead continued look our under across sustain of pleased normalize. Overall, and elective areas; our for we our We procedures second to opportunities of growth focus balance target XXXX, quarter sheet execution positions and as two, going second in to forward. well number adjacent our our with half the performance improvement the our remains capabilities. invest efficiency; as the especially of on operational initiatives; our we
CFO, call to would second a turn Jensen quarter the discussion XXXX of for over like to results. our Greg I financial Now, our
